NCT01634308已完成3 期
Efficacy and Safety of Bongros-BMP Compared to Bio-oss for Regeneration of Alveolar Bone Tissue After Maxillary Sinus Floor Augmentation
Daewoong Pharmaceutical Co. LTD.1 个研究点 分布在 1 个国家开始时间: 2010年6月最近更新:
适应症
干预措施
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 试验地点
- 1
研究概览
简要总结
The purpose of this Clinical study was to evaluate the Efficacy and Safety of bongros-BMP compared to Bio-oss for Regeneration of alveolar bone tissue after Maxillary sinus floor augmentation.
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- 未提供
排除标准
- 未提供
研究组 & 干预措施
Novosis(bongros/BMP-2)
Experimental
干预措施: Novosis(bongros/BMP-2) (Drug)
Bio-oss
Active Comparator
干预措施: Bio-oss (Drug)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
1 期
Study to Evaluate the Safety, Pharmacokinetics and Target Engagement of BMS-986142 in Healthy SubjectsHealthy AdultNCT02257151Bristol-Myers Squibb118
终止
2 期
An Investigational Study to Evaluate the Safety and Effectiveness of BMS-986165 With Background Treatment in Participants With Lupus NephritisLupus NephritisNCT03943147Bristol-Myers Squibb16
进行中（未招募）
3 期
A Study to Compare the Efficacy and Safety of BMS-986365 Versus the Investigator's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate CancerMetastatic Castration-resistant Prostate CancerNCT06764485Celgene960
已完成
4 期
PEG-rhG-CSF in Patients With Breast Cancer Receiving ChemotherapyBreast CancerNCT02805153CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.215
已完成
1 期
Study of BMS-562086 in the Treatment of Outpatients With Major Depressive DisorderMajor Depressive DisorderNCT00135421Bristol-Myers Squibb271